Laparoscopic sleeve gastrectomy in obese Korean patients: up to 4-year follow-up in a single center
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Ji Yeon | - |
dc.contributor.author | Kim, Yong Jin | - |
dc.date.accessioned | 2021-08-11T20:25:18Z | - |
dc.date.available | 2021-08-11T20:25:18Z | - |
dc.date.issued | 2015-05 | - |
dc.identifier.issn | 2288-6575 | - |
dc.identifier.issn | 2288-6796 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/10686 | - |
dc.description.abstract | Purpose: Laparoscopic sleeve gastrectomy (LSG) has been gaining marked popularity as a stand-alone treatment for morbid obesity. This study aimed to evaluate the midterm outcomes and efficacy of LSG performed at a single center in Korea. Methods: The records of 192 consecutive patients who underwent LSG between April 2009 and December 2012 were retrospectively reviewed. The patients demographics and surgical outcomes including anthropometric data were analyzed. Results: The mean preoperative body mass index was 40.0 +/- 7.2 kg/m(2), and 120 patients (62.5%) had at least one obesity-related comorbidity. Three patients (1.6%) required endoscopic or surgical intervention to manage postoperative bleeding or leakage. At the postoperative 1-, 2-, 3-, and 4-year follow-ups, the mean percent of excess weight loss (%EWL) values were 72.6%, 80.6%, 71.1%, and 57.8%, respectively, with follow-up rates of 81%, 56%, 58%, and 30% respectively. The overall mean %EWL reached 68.3% 27.2% at a mean follow-up of 25 months. Obesity-related comorbidities were resolved in >70% of the patients after surgery. Twelve months after LSG, 25 patients (13.0%) showed a %EWL of <50%; 9 (4.79/0) required conversion to gastric bypass due to inadequate weight loss, intolerable reflux symptoms, or intractable diabetes. Conclusion: These midterm results show that LSO is a safe and effective surgical procedure for morbidly obese patients. However, a longer follow-up period is necessary to elucidate whether LSG can achieve durable weight loss and tong-term outcomes, comparable to those of more aggressive procedures. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한외과학회 | - |
dc.title | Laparoscopic sleeve gastrectomy in obese Korean patients: up to 4-year follow-up in a single center | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.4174/astr.2015.88.5.246 | - |
dc.identifier.scopusid | 2-s2.0-84981352021 | - |
dc.identifier.wosid | 000354419000002 | - |
dc.identifier.bibliographicCitation | 대한외과학회지, v.88, no.5, pp 246 - 252 | - |
dc.citation.title | 대한외과학회지 | - |
dc.citation.volume | 88 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 246 | - |
dc.citation.endPage | 252 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001984360 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.subject.keywordPlus | Y GASTRIC BYPASS | - |
dc.subject.keywordPlus | HIGH-RISK PATIENTS | - |
dc.subject.keywordPlus | WEIGHT-LOSS | - |
dc.subject.keywordPlus | MORBID-OBESITY | - |
dc.subject.keywordPlus | BILIOPANCREATIC DIVERSION | - |
dc.subject.keywordPlus | BARIATRIC OPERATION | - |
dc.subject.keywordPlus | DUODENAL SWITCH | - |
dc.subject.keywordPlus | EXPERIENCE | - |
dc.subject.keywordPlus | LEAKS | - |
dc.subject.keywordAuthor | Morbid obesity | - |
dc.subject.keywordAuthor | Bariatric surgery | - |
dc.subject.keywordAuthor | Laparoscopy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.